Cabeza Montilla, Laura Author
Gemcitabine-loaded magnetically responsive poly(ε-caprolactone) nanoparticles against breast cancer
- García-García G.
- Fernández-álvarez F.
- Cabeza L.
- Delgado Á.V.
- Melguizo C.
- Prados J.C.
- Arias J.L.
Polymers - 1/12/2020
- JCR Impact Factor: 4.329 (2020)
- JCR 5-year Impact Factor: 4.493
- JCR Categories: POLYMER SCIENCE
- Scopus
- ORCID
- Web of Science
MMR-proficient and MMR-deficient colorectal cancer cells: 5-Fluorouracil treatment response and correlation to CD133 and MGMT expression
- Oliver J.A.
- Ortiz R.
- Jiménez-Luna C.
- Cabeza L.
- Perazzoli G.
- Caba O.
- Mesas C.
- Melguizo C.
- Prados J.
Journal of Biosciences - 1/12/2020
- JCR Quartile: Q3 (2020)
- JCR Impact Factor: 1.826 (2022)
- Category normalized Impact: 0.383 (2020)
- CiteScore: 2.1 (2020)
- SJR: 0.459 (2020
- SNIP: 0.489 (2020
- JCR 5-year Impact Factor: 2.107
- JCR Categories: BIOLOGY
- Scopus
- ORCID
- Web of Science
Cancer therapy based on extracellular vesicles as drug delivery vehicles
Journal of Controlled Release - 10/11/2020
- SJR Quartile: Q1
- JCR Impact Factor: 9.776 (2020)
- CiteScore: 14.2 (2020)
- SJR: 2.119 (2020
- SNIP: 1.748 (2020
- JCR 5-year Impact Factor: 10.413
- JCR Categories: CHEMISTRY, MULTIDISCIPLINARY
- SJR Categories: Pharmaceutical Science (Q1)
Novel MicroRNA Sponges to Specifically Modulate Gene Expression in Colon Cancer Cells
- Rama A.R.
- Perazzoli G.
- Cabeza L.
- Mesas C.
- Quiñonero F.
- García-Pinel B.
- Vélez C.
Nucleic Acid Therapeutics - 1/10/2020
- JCR Impact Factor: 5.486 (2020)
- CiteScore: 9.1 (2020)
- SJR: 2.255 (2020
- SNIP: 1.076 (2020
- JCR 5-year Impact Factor: 4.521
- JCR Categories: MEDICINE, RESEARCH & EXPERIMENTAL
Magnetically active pNIPAM nanosystems as temperature-sensitive biocompatible structures for controlled drug delivery
- Garcia-Pinel B.
- Ortega-Rodríguez A.
- Porras-Alcalá C.
- Cabeza L.
- Contreras-Cáceres R.
- Ortiz R.
- Díaz A.
- Moscoso A.
- Sarabia F.
- Prados J.
- López-Romero J.M.
- Melguizo C.
Artificial Cells Nanomedicine and Biotechnology - 1/1/2020
- JCR Quartile: Q1 (2020)
- JCR Impact Factor: 5.678 (2022)
- Category normalized Impact: 1.322 (2020)
- CiteScore: 8.3 (2020)
- SJR: 0.935 (2020
- SNIP: 1.163 (2020
- JCR 5-year Impact Factor: 5.246
- JCR Categories: MATERIALS SCIENCE, BIOMATERIALS
- Scopus
- ORCID
- Web of Science
Oxaliplatin–biomimetic magnetic nanoparticle assemblies for colon cancer-targeted chemotherapy: An in vitro study
- Jabalera Y.
- Garcia-Pinel B.
- Ortiz R.
- Iglesias G.
- Cabeza L.
- Prados J.
- Jimenez-Lopez C.
- Melguizo C.
Pharmaceutics - 1/8/2019
- SJR Quartile: Q1
- JCR Impact Factor: 4.421 (2019)
- JCR Categories: PHARMACOLOGY & PHARMACY
- SJR Categories: Pharmaceutical Science (Q1)
- Scopus
- ORCID
- Web of Science
Electrospun nanofibers: Recent applications in drug delivery and cancer therapy
- Contreras-Cáceres R.
- Cabeza L.
- Perazzoli G.
- Díaz A.
- López-Romero J.
- Melguizo C.
- Prados J.
Nanomaterials - 1/4/2019
- SJR Quartile: Q1
- JCR Impact Factor: 4.324 (2019)
- CiteScore: 4.21 (2018)
- SJR: 0.896 (2018
- SNIP: 1.112 (2018
- JCR 5-year Impact Factor: 4.514
- JCR Categories: NANOSCIENCE & NANOTECHNOLOGY
- SJR Categories: Chemical Engineering (miscellaneous) (Q1); Materials Science (miscellaneous) (Q1)
- Scopus
- ORCID
- Web of Science
An updated review of adipose derived-mesenchymal stem cells and their applications in musculoskeletal disorders
- Rivera-Izquierdo M.
- Cabeza L.
- Láinez-Ramos-Bossini A.
- Quesada R.
- Perazzoli G.
- Alvarez P.
- Prados J.
- Melguizo C.
EXPERT OPINION ON BIOLOGICAL THERAPY - 4/3/2019
- SJR Quartile: Q1
- JCR Impact Factor: 3.224 (2019)
- CiteScore: 6.4 (2020)
- SJR: 0.917 (2019
- SNIP: 0.76 (2019
- JCR 5-year Impact Factor: 3.109
- JCR Categories: MEDICINE, RESEARCH & EXPERIMENTAL
- SJR Categories: Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q2)
- Scopus
- ORCID
- Web of Science
A novel nanoformulation of PLGA with high non-ionic surfactant content improves in vitro and in vivo PTX activity against lung cancer
- Jiménez-López J.
- El-Hammadi M.
- Ortiz R.
- Cayero-Otero M.
- Cabeza L.
- Perazzoli G.
- Martin-Banderas L.
- Baeyens J.
- Prados J.
- Melguizo C.
PHARMACOLOGICAL RESEARCH - 1/3/2019
- SJR Quartile: Q1
- JCR Impact Factor: 5.893 (2019)
- CiteScore: 10.1 (2020)
- SJR: 1.609 (2019
- SNIP: 1.483 (2019
- JCR 5-year Impact Factor: 5.631
- JCR Categories: PHARMACOLOGY & PHARMACY
- SJR Categories: Pharmacology (Q1)
- Scopus
- ORCID
- Web of Science
Double origin of the extensor hallucis longus muscle: a case report
- Egea J.
- Cabeza L.
- Ortiz R.
- Rama A.
- Melguizo C.
- Prados J.
SURGICAL AND RADIOLOGIC ANATOMY - 1/12/2019
- SJR Quartile: Q2
- JCR Impact Factor: 1.092 (2019)
- CiteScore: 1.9 (2020)
- SJR: 0.487 (2019
- SNIP: 1.069 (2019
- JCR 5-year Impact Factor: 1.229
- JCR Categories: SURGERY
- SJR Categories: Anatomy (Q2); Surgery (Q2); Pathology and Forensic Medicine (Q3); Radiology, Nuclear Medicine and Imaging (Q3)
- Scopus
- ORCID
- Web of Science
Combinaciones terapéuticas y sus ventajas en el tratamiento del síndrome de dolor miofascial
- Laura Cabeza
- Gloria Perazzoli
- Ester Calzado Bon
Acercamiento multidisciplinar a la salud: Volumen IV - 2019
- Dialnet
Efectos del trabajo a turnos en enfermeras del servicio de urgencias hospitalarias entre 55 y 65 años en las etapas menopausia y post-menopausia
- Laura Cabeza
- Gloria Perazzoli
- Ester Calzado Bon
Investigación en salud y envejecimiento: Volumen VI - 2019
- Dialnet
Mejora de la actividad antitumoral de agentes citotóxicos mediante el uso de nanoplataformas poliméricas: aplicación en cáncer de colon, mama y pulmón
- Laura Cabeza
- Consolación Melguizo
- José Carlos Prados Salazar
- Raul Ortiz Quesada
2017
- Dialnet
This author has no conferences.
This author has no patents.
Nanomedicine and Hyperthermia for the Treatment of Gastrointestinal Cancer: A Systematic Review
- Lidia Gago
- Francisco Quiñonero
- Gloria Perazzoli
- Consolacion Melguizo
- Jose Prados
- Raul Ortiz
- Laura Cabeza
Pharmaceutics - 13/06/2023
- Scopus
- ORCID
- Web of Science
Correction: Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer (Cancer Gene Therapy, (2019), 10.1038/s41417-019-0137-3)
- Ballesteros A.
- Hernández R.
- Perazzoli G.
- Cabeza L.
- Melguizo C.
- Vélez C.
- Prados J.
CANCER GENE THERAPY - 1/1/2020
- JCR Impact Factor: 5.987 (2020)
- CiteScore: 8.1 (2020)
- SJR: 1.535 (2020
- SNIP: 1.113 (2020
- JCR 5-year Impact Factor: 5.358
- JCR Categories: MEDICINE, RESEARCH & EXPERIMENTAL
h index
Scopus: 13
Web of Science: 21
i10 index
Scopus: 18
Web of Science: 30
Author profiles
-
ORCID
-
Web of Science ResearcherID
-
Scopus Author ID
-
Dialnet id
Research projects at UAL
-
Acronym CV20-78799Since: September 8, 2020Until: September 7, 2021Funded by: JUNTAFunding / grant amount: 60,000.00 EURRole: Investigador